Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Aspen Aerogels (ASPN) EBITDA (2016 - 2025)

Aspen Aerogels (ASPN) has disclosed EBITDA for 13 consecutive years, with -$3.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBITDA fell 119.24% year-over-year to -$3.3 million, compared with a TTM value of -$293.1 million through Sep 2025, down 811.4%, and an annual FY2024 reading of $54.5 million, up 210.84% over the prior year.
  • EBITDA was -$3.3 million for Q3 2025 at Aspen Aerogels, up from -$5.2 million in the prior quarter.
  • Across five years, EBITDA topped out at $20.0 million in Q2 2024 and bottomed at -$299.3 million in Q1 2025.
  • Average EBITDA over 5 years is -$22.2 million, with a median of -$9.7 million recorded in 2022.
  • The sharpest move saw EBITDA soared 963.85% in 2024, then plummeted 12388.22% in 2025.
  • Year by year, EBITDA stood at -$16.3 million in 2021, then surged by 40.74% to -$9.7 million in 2022, then soared by 114.31% to $1.4 million in 2023, then skyrocketed by 963.85% to $14.7 million in 2024, then crashed by 122.76% to -$3.3 million in 2025.
  • Business Quant data shows EBITDA for ASPN at -$3.3 million in Q3 2025, -$5.2 million in Q2 2025, and -$299.3 million in Q1 2025.